PeDRA 2025Abstract 067
Dupilumab Safety and Efficacy Up to 3 Years Across Racial Subgroups in Pediatric Patients Aged 6 Months to 11 Years With Atopic Dermatitis
Siegfried E, Cork M, Gonzalez M, Aschoff R, Alexis A, Aldredge L, Chen Z, Prescilla R, Nguyen T
PeDRA Annual Conference 2025Minneapolis, 9–11 Oct 2025 · published in JID 9 Mar 2026
Topics: Atopic dermatitis & eczemaPediatric dermatology
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/s0022-202x(26)00603-2 · Not in PubMed: details from Crossref